Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: November 11, 2025
Experience Using Ustekinumab in Pediatric Patients With Medically Refractory Crohn Disease.
Journal: Journal of pediatric gastroenterology and nutrition
Published: August 20, 2021
Showing 1-2 of 2
Last Updated: 09/26/2026